TerrenceJBradleyMD

PubMed

• 44 citations
  Magrolimab in Combination With Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes: Final Results of a Phase Ib Study.
  David A Sallman, Monzr M Al Malki, Adam S Asch, Eunice S Wang, Joseph G Jurcic
  Journal of Clinical Oncology. 2023-05-20
• 81 citations
  Venetoclax Plus Gilteritinib for-Mutated Relapsed/Refractory Acute Myeloid Leukemia.
  Naval Daver, Alexander E Perl, Joseph Maly, Mark Levis, Ellen Ritchie
  Journal of Clinical Oncology. 2022-12-10
• 1 citations
  Tyrosine phosphorylation of CARM1 promotes its enzymatic activity and alters its target specificity.
  Hidehiro Itonaga, Adnan K Mookhtiar, Sarah M Greenblatt, Fan Liu, Concepcion Martinez
  Nature Communications. 2024-04-22

Abstracts/Posters

• A Phase 2a Study of the LSD1 Inhibitor Img-7289 (bomedemstat) for the Treatment of Myelofibrosis
  Terrence J Bradley, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Preliminary Results from a Phase II Study of the Combination of Pevonedistat and Azacitidine in the Treatment of MDS and MDS/MPN after Failure of DNA Methyltransferase...
  Terrence J Bradley, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• A Phase I/II Study to Investigate the Safety and Clinical Activity of the Protein Arginine Methyltransferase 5 Inhibitor GSK3326595 in Subjects with Myelodysplastic Sy...
  Terrence J Bradley, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Safety and Efficacy of Midostaurin in Combination with High-Dose Daunorubicin in 7+3 Induction for Acute Myeloid Leukemia with FLT3 Mutation
  Terrence J Bradley, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all

Lectures

• Increased Frequency of IDH1/2 Mutations in Extramedullary Acute Myeloid Leukemia 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018